Previous 10 |
home / stock / invvy / invvy news
SLOUGH, England and RICHMOND, Va. , Jan. 19, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that it will release its full year 2017 results on February 15 th at 7:00 a.m. London time ( 2:00 a.m. U.S. EST). The results will be available via the London Stock...
The following slide deck was published by INDIVIOR PLC ADR in conjunction with this Read more ...
SLOUGH, England and RICHMOND, Va. , Jan. 4, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that Shaun Thaxter , CEO, will present at the 36 th Annual J.P. Morgan Healthcare Conference on January 11th, 2018 , at 8:30 a.m. local Pacific time ( 11:30 a.m. Eastern ...
SLOUGH, England and RICHMOND, Va. , Jan. 3, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior") today announced that Indivior UK Limited has entered into a strategic collaboration with Addex Pharma S.A., a wholly-owned subsidiary of Addex Therapeutics Ltd. (SIX: A...
News, Short Squeeze, Breakout and More Instantly...
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance PR Newswire RICHMOND, Va. , May 23, 2024 /PRNewswire/ -- Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, announced that in anticipation o...
Indivior Announces Q1 2024 Financial Results PR Newswire SLOUGH, United Kingdom and RICHMOND, Va. , April 25, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024 . The earnings re...
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone PR Newswire This head-to-head pharmacodynamic study in healthy volunteers...